Market Cap (In AUD)
4.32 Million
Revenue (In AUD)
2.21 Million
Net Income (In AUD)
-4.87 Million
Avg. Volume
1.4 Million
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.036-0.755
- PE
- -
- EPS
- -
- Beta Value
- 0.193
- ISIN
- AU0000053324
- CUSIP
- Q71630109
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Dr. Yujing Lim
- Employee Count
- -
- Website
- https://www.osteopore.com
- Ipo Date
- 2019-09-23
- Details
- Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. Osteopore Limited has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. The company was incorporated in 2003 and is headquartered in Singapore.
More Stocks
-
2885
-
5216Kuramoto Co., Ltd.
5216
-
CUBWWLionheart Holdings
CUBWW
-
2371
-
600618
-
002172
-
VEGGD
-
FHYDFirst Hydrogen Corp.
FHYD